Global Brain And Neuroimaging Devices Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

The global brain and neuroimaging devices market is segmented by imaging type, modality, application, end user, and geography. Imaging type includes advanced technologies such as functional magnetic resonance imaging (fMRI), computed tomography (CT), positron emission tomography (PET), electroencephalography (EEG), magnetoencephalography (MEG), and others. Among these, fMRI and CT dominate due to their widespread adoption in diagnostic and research settings. PET and MEG are gaining traction for their precise functional imaging capabilities, while EEG continues to play a critical role in neurological assessments.

Based on modality, the market is categorized into fixed and portable systems. Fixed systems, often found in well-equipped hospitals and diagnostic centers, represent the largest share due to their superior imaging quality and integration with advanced software. However, portable systems are experiencing rapid growth driven by technological advancements and increasing demand for point-of-care imaging in remote and ambulatory settings. Their lightweight and easy-to-operate features make them a favorable option for resource-limited environments.

In terms of application, the market caters to conditions such as epilepsy and brain tumors, with applications expanding to other neurological disorders. Epilepsy imaging is a significant segment due to the prevalence of the disease and the demand for accurate diagnostics. Imaging for brain tumors is also critical, as precise localization and monitoring are essential for treatment planning. Both segments are expected to grow with increasing awareness and advancements in imaging technologies.

Geographically, the market is divided into North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. North America leads due to high healthcare expenditure, technological innovation, and a robust healthcare infrastructure. Europe follows closely with substantial investments in research and development. Asia Pacific is expected to witness the fastest growth, driven by a rising burden of neurological disorders, improving healthcare access, and government initiatives. Meanwhile, the Middle East, Africa, and Latin America are gradually expanding their market share through improved healthcare policies and growing demand for advanced diagnostic tools.

Global Brain And Neuroimaging Devices Segment Analysis

In this report, the Global Brain And Neuroimaging Devices Market has been segmented by Imaging Type, Modality, Application, End User and Geography.

Global Brain And Neuroimaging Devices Market, Segmentation by Imaging Type

The Global Brain And Neuroimaging Devices Market has been segmented by Imaging Type into Functional Magnetic Resonance Imaging (fMRI), Computed Tomography (CT), Positron Emission Tomography (PET), Electroencephalography (EEG), Magneto Encephalography (MEG) and Others.

FMRI is a powerful tool that measures brain activity by detecting changes in blood flow. It is widely used to map brain function, study cognitive processes, and localize regions associated with sensory and motor functions. fMRI plays a crucial role in understanding neurological disorders such as Alzheimer's disease, schizophrenia, and stroke.

CT scans provide detailed cross-sectional images of the brain using X-rays. This imaging modality is essential for diagnosing acute conditions like hemorrhages, tumors, and traumatic brain injuries. CT scans are rapid and widely available, making them valuable in emergency settings for immediate assessment and treatment planning.

PET imaging involves injecting radioactive tracers into the bloodstream to visualize metabolic activity in the brain. It is particularly useful for detecting cancerous cells, assessing neurological conditions such as Alzheimer's disease, and monitoring treatment responses. PET scans offer insights into both structural and functional aspects of brain activity.

EEG records electrical activity in the brain using electrodes placed on the scalp. It is crucial for diagnosing epilepsy, sleep disorders, and monitoring brain function during surgery. EEG is non-invasive and provides real-time data on brain waves, aiding in the localization of abnormal activity and guiding treatment decisions.

MEG measures magnetic fields generated by neuronal activity in the brain. It offers high spatial and temporal resolution, making it valuable for mapping brain function with precision. MEG is used in research settings to study brain dynamics, localize epileptic foci, and understand sensory processing.

This category includes emerging neuroimaging technologies and less commonly used modalities such as functional near-infrared spectroscopy (fNIRS), diffusion tensor imaging (DTI), and SPECT (Single Photon Emission Computed Tomography). These technologies contribute to the comprehensive toolkit available for diagnosing and studying neurological disorders.

Global Brain And Neuroimaging Devices Market, Segmentation by Modality

The Global Brain And Neuroimaging Devices Market has been segmented by Modality into Fixed, Portable.

The global brain and neuroimaging devices market is categorized based on modality into two primary segments: fixed and portable systems. Fixed neuroimaging devices are typically found in hospitals, diagnostic centers, and research facilities. These systems are designed for comprehensive and high-resolution imaging, providing detailed insights into neurological conditions. Their advanced capabilities make them ideal for complex diagnostics and long-term patient monitoring, although they are not easily transportable due to their size and infrastructure requirements.

Portable neuroimaging devices, on the other hand, are compact and designed for mobility. These devices are particularly useful in emergency settings, field research, and point-of-care diagnostics, where immediate imaging is essential. They offer flexibility and ease of use, enabling clinicians to perform neurological assessments in diverse locations, including patient homes and smaller clinics. Despite their mobility, advancements in technology ensure that portable devices maintain a reasonable standard of imaging quality.

The segmentation highlights the varying needs and applications in the healthcare and research sectors. Fixed systems are more suitable for institutions with the capacity to accommodate large equipment, while portable devices cater to scenarios requiring quick deployment and accessibility. This diversity in modality allows the market to address a wide range of clinical and operational demands, driving innovation and adoption across different healthcare settings.

Global Brain And Neuroimaging Devices Market, Segmentation by Application

The Global Brain And Neuroimaging Devices Market has been segmented by Application into Epilepsy, Brain Tumor.

The global brain and neuroimaging devices market is categorized by application into epilepsy and brain tumor diagnosis and treatment. These applications represent key areas where neuroimaging technologies play a pivotal role in advancing medical care. Epilepsy, a neurological disorder characterized by recurrent seizures, requires precise imaging to identify abnormalities in brain activity and structure. Technologies like functional MRI (fMRI) and electroencephalogram (EEG) are commonly employed to pinpoint seizure origins, enabling targeted treatment plans such as surgery or neurostimulation.

For brain tumors, neuroimaging is indispensable in detecting, diagnosing, and monitoring the progression of tumors. Imaging modalities such as magnetic resonance imaging (MRI) and computed tomography (CT) scans provide high-resolution visualization of brain tissues, aiding in the differentiation between benign and malignant tumors. These devices also guide surgical procedures and evaluate the effectiveness of treatments like chemotherapy or radiation therapy, underscoring their importance in comprehensive tumor management.

The segmentation highlights the growing demand for advanced neuroimaging devices tailored to these specific conditions. The focus on epilepsy and brain tumor applications reflects the critical need for precise diagnostic tools in managing complex neurological disorders. As technological advancements continue to improve imaging accuracy and efficiency, these devices are anticipated to play an increasingly significant role in improving patient outcomes and fostering innovation in neuroscience research and clinical practice.

Global Brain And Neuroimaging Devices Market, Segmentation by End User

The Global Brain And Neuroimaging Devices Market has been segmented by End User into Hospitals, Diagnostic Centres and Ambulatory Surgical Centres.

Hospitals are the primary end-users of brain and neuroimaging devices, accounting for a significant share of the market. Hospitals use these devices for a wide range of diagnostic and therapeutic purposes related to neurological disorders and conditions. Neuroimaging technologies such as MRI, CT, PET, EEG, and others are integral to the diagnostic workflows in hospitals, aiding in the assessment of stroke, tumors, traumatic brain injuries, epilepsy, and other neurological conditions. Hospitals often have comprehensive neurology departments equipped with advanced imaging facilities to cater to both inpatient and outpatient diagnostic needs.

Diagnostic centres specialize in providing imaging services, including neuroimaging, to patients referred by healthcare providers. These centres are equipped with state-of-the-art imaging technologies such as MRI, CT, PET, and others, offering specialized diagnostic capabilities for neurological assessments. Diagnostic centres play a crucial role in delivering timely and accurate neuroimaging services, often with shorter waiting times compared to hospital settings. They serve as key partners to healthcare providers in the diagnosis, monitoring, and management of neurological disorders.

Ambulatory surgical centres (ASCs) are outpatient facilities that perform surgical procedures requiring less than 24 hours of hospitalization. While their primary focus is on surgical interventions, ASCs also utilize neuroimaging devices for pre-operative planning, intra-operative guidance, and post-operative monitoring. Neuroimaging technologies such as MRI and CT are employed in ASCs to assist in surgical decision-making, ensuring optimal outcomes for patients undergoing neurosurgical procedures.

Global Brain And Neuroimaging Devices Market, Segmentation by Geography

In this report, the Global Brain And Neuroimaging Devices Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Global Brain And Neuroimaging Devices Market Share (%), by Geographical Region, 2024

North America holds a prominent position in the brain and neuroimaging devices market, driven by advanced healthcare infrastructure, high healthcare expenditure, and robust research and development activities. The region is characterized by widespread adoption of advanced neuroimaging technologies such as MRI, CT, PET, and EEG in clinical practice and research. Increasing prevalence of neurological disorders, coupled with favorable reimbursement policies, fuels market growth. Major market players in North America focus on innovation and technological advancements, catering to the diagnostic needs of hospitals, diagnostic centres, and ambulatory surgical centres.

Europe is a significant market for brain and neuroimaging devices, supported by well-established healthcare systems and strong regulatory frameworks. Countries in Western Europe lead in terms of market size and adoption of neuroimaging technologies for both diagnostic and research purposes. The region benefits from extensive research collaborations and investments in neuroscience, driving advancements in imaging modalities and applications. Increasing geriatric population and rising incidence of neurological disorders contribute to market growth in Europe, with hospitals and diagnostic centres playing pivotal roles in neuroimaging utilization.

Asia Pacific represents a rapidly growing market for brain and neuroimaging devices, fueled by expanding healthcare infrastructure, rising healthcare expenditure, and increasing awareness about neurological disorders. Countries like China, India, Japan, and South Korea are at the forefront of market expansion, driven by technological advancements and growing investments in healthcare. The region experiences a surge in demand for neuroimaging technologies in both urban and rural healthcare settings, supported by government initiatives to improve healthcare access and quality. Local and international manufacturers are leveraging this growth opportunity by introducing innovative neuroimaging solutions tailored to regional needs.

The Middle East and Africa region exhibit a developing market for brain and neuroimaging devices, characterized by improving healthcare infrastructure and rising healthcare investments. While the market is smaller compared to other regions, there is increasing adoption of neuroimaging technologies in major urban centers and specialized healthcare facilities. Governments in the region are investing in healthcare infrastructure development, including neurology departments and diagnostic capabilities, driving market expansion. Neuroimaging plays a crucial role in diagnosing and managing neurological conditions prevalent in the region, such as stroke and epilepsy.

Latin America represents a growing market for brain and neuroimaging devices, driven by improving healthcare access, rising healthcare expenditure, and increasing prevalence of neurological disorders. Countries like Brazil, Mexico, and Argentina lead in market size and adoption of neuroimaging technologies, supported by advancements in healthcare infrastructure and regulatory frameworks. The region's market growth is bolstered by collaborations between healthcare providers and technology vendors to enhance diagnostic capabilities and expand neuroimaging services across hospitals, diagnostic centres, and ambulatory surgical centres.

This report provides an in depth analysis of various factors that impact the dynamics of Global Brain And Neuroimaging Devices Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.

Drivers, Restraints and Opportunity Analysis

Drivers:

• Technological advancements
• Increasing neurological disorders

• Rising healthcare expenditure - Rising healthcare expenditure is a significant global trend that impacts various facets of healthcare delivery, including the market for brain and neuroimaging devices. Globally, healthcare expenditure has been steadily increasing due to several factors. Firstly, demographic shifts such as aging populations in many developed countries drive higher demand for healthcare services, including diagnostic procedures like neuroimaging. As people age, they are more prone to neurological conditions, prompting increased utilization of advanced imaging technologies to diagnose and monitor these ailments.

  Advancements in medical technologies, including neuroimaging devices, contribute to rising healthcare costs. While these technologies offer improved diagnostic accuracy and patient outcomes, they often come with substantial upfront costs for equipment acquisition, maintenance, and specialized training for healthcare professionals. This technological advancement paradoxically both drives up expenditure and enhances the quality of care available.

  The global expansion of healthcare infrastructure and services, particularly in emerging markets, plays a pivotal role in increasing healthcare spending. Governments and private sectors in countries like China, India, and Brazil are investing heavily in healthcare facilities and technologies to meet the growing demands of their populations. This expansion includes the adoption of advanced diagnostic tools, including brain and neuroimaging devices, to improve diagnostic capabilities and patient care standards.

Restraints:

• High costs
• Limited accessibility in developing regions

• Technological complexity - Technological complexity in the context of brain and neuroimaging devices refers to the intricacy and sophistication of the equipment and processes involved in these diagnostic tools. This complexity presents both challenges and opportunities for the industry.

  The complexity of neuroimaging technologies such as MRI, CT, PET, EEG, and MEG requires specialized knowledge and skills for operation and interpretation. Healthcare professionals, including radiologists, neurologists, and technicians, need extensive training to effectively use these devices and interpret the data they provide. This demand for skilled personnel can create barriers to adoption, particularly in regions with limited access to training programs or educational resources.

  The rapid pace of technological advancements in neuroimaging introduces ongoing complexity. Newer generations of imaging devices offer enhanced resolution, faster scanning times, and improved diagnostic capabilities. However, integrating these advancements into existing healthcare infrastructures can be challenging and costly. Healthcare facilities must continually upgrade equipment, invest in training staff, and navigate regulatory requirements to ensure safe and effective use.

  The complexity of neuroimaging technologies often results in higher costs. The initial investment in equipment, ongoing maintenance, and upgrades contribute to the overall cost of healthcare services. Additionally, complex imaging processes may require longer examination times, leading to operational inefficiencies and increased patient waiting times.

Opportunities:

• Emerging markets
• Personalized medicine

• Telemedicine - Telemedicine refers to the use of telecommunications technology to provide healthcare services remotely, facilitating diagnosis, consultation, treatment, and monitoring of patients. This approach has gained significant prominence and acceptance globally, driven by several factors that highlight its potential and benefits:

  Telemedicine enhances access to healthcare services, especially in remote or underserved areas where healthcare facilities and specialists may be scarce. Patients can consult with neurologists and receive neuroimaging interpretations without needing to travel long distances, reducing barriers to care and improving healthcare access.

  By enabling remote consultations and diagnostics, telemedicine optimizes healthcare delivery processes. It reduces healthcare costs associated with travel, waiting times, and unnecessary hospital visits. Moreover, healthcare providers can utilize resources more efficiently, potentially decreasing overall healthcare expenditure.

  Telemedicine supports continuity of care by facilitating regular follow-ups and monitoring of neurological conditions. Patients can receive ongoing support and adjustments to treatment plans remotely, leading to better management of chronic conditions and improving patient outcomes.

Key players in Global Brain And Neuroimaging Devices Market include:

• GE Healthcare
• Siemens Healthineers
• Philips Healthcare
• Canon Medical Systems
• Hitachi Medical Systems

In this report, the profile of each market player provides following information:

• Company Overview and Product Portfolio
• Key Developments
• Financial Overview
• Strategies
• Company SWOT Analysis